SCHEMBL1709561

SCHEMBL1709561

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNC(=O)N2CCCCC2)n(C)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.45
GAA P10253 1/20 0.35
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MC4R P32245 2/20 0.33
MLLT1 Q03111 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
MAPT P10636 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32
CTSS P25774 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709610 0.92 GHSR (0.38) GHSRGAAEPHX2KDM4EKMT2A
SCHEMBL1709686 0.92 GHSR (0.45) GHSRGAAEPHX2KDM4EKMT2A
SCHEMBL1709639 0.91 GHSR (0.45) GHSRGAAEPHX2KDM4EKMT2A
SCHEMBL10122249 0.88 GHSR (0.46) GHSRGAAKMT2AALDH1A1L3MBTL1
SCHEMBL1709573 0.88 GHSR (0.44) GHSRGAAALDH1A1MC4RCHRM2
SCHEMBL1709734 0.87 GHSR (0.49) GHSRGAAEPHX2KDM4EKMT2A
SCHEMBL1709566 0.87 GHSR (0.45) GHSRGAAEPHX2KDM4EKMT2A
SCHEMBL1709679 0.87 GHSR (0.47) GHSRGAAEPHX2KMT2AALDH1A1
SCHEMBL1709729 0.86 GHSR (0.48) GHSRGAAKMT2AALDH1A1SCN1A
SCHEMBL10121710 0.86 GHSR (0.48) GHSRGAAKDM4EKMT2ASCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885GAA 55/4885EPHX2 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.